| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |